Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Wörner

Showing results (1-10 of 32) with videos related to

Pageof 4
Sort By:
Pharmazie in Unserer Zeit|March 10, 2001
[Pharmaceutical service to patients with insulin-dependent diabetes mellitus]W Wörner
Der Chirurg; Zeitschrift Fur Alle Gebiete Der Operativen Medizen|October 1, 1979
[Gastric bypass in the surgical treatment of extreme adiposity]B Husemann, W Wörner
FEBS Letters|May 21, 1984
Identity of dihydrodiol dehydrogenase and 3 alpha-hydroxysteroid dehydrogenase in rat but not in rabbit liver cytosolW Wörner, F Oesch
Infusionstherapie Und Klinische Ernahrung|June 1, 1986
[Possibilities for the use of formula diets for tumor patients]M Keymling, W Wörner
FEBS Letters|September 20, 1982
Kirromycin-resistant elongation factor Tu from wild-type of Lactobacillus brevisW Wörner, H Wolf
Beitrage Zu Infusionstherapie Und Klinische Ernahrung|January 1, 1986
[Possibilities for the use of formula diets in tumor patients]M Keymling, W Wörner
Environmental Toxicology and Pharmacology|July 26, 2011
2,3,7,8-Tetrachlorodibenzo-p-dioxin suppresses apoptosis and leads to hyperphosphorylation of p53 in rat hepatocytesW Wörner, D Schrenk
European Journal of Clinical Pharmacology|January 1, 1992
Drug-protein binding kinetics in patients with type I diabetesW Wörner, A Preissner, N Rietbrock
Deutsche Medizinische Wochenschrift (1946)|January 30, 1987
[Percutaneous endoscopy-controlled gastrostomy]M Keymling, P Schlee, W Wörner
Biochemical and Biophysical Research Communications|August 1, 1982
Kirromycin-resistant elongation factor Tu from pulvomycin-producing wild-type of Streptoverticillium mobaraenseC Glöckner, W Wörner, H Wolf
Pageof 4

Showing results (1-10 of 32) with videos related to

Sort By:
Pageof 4
Pharmazie in Unserer Zeit|March 10, 2001
[Pharmaceutical service to patients with insulin-dependent diabetes mellitus]W Wörner
Der Chirurg; Zeitschrift Fur Alle Gebiete Der Operativen Medizen|October 1, 1979
[Gastric bypass in the surgical treatment of extreme adiposity]B Husemann, W Wörner
FEBS Letters|May 21, 1984
Identity of dihydrodiol dehydrogenase and 3 alpha-hydroxysteroid dehydrogenase in rat but not in rabbit liver cytosolW Wörner, F Oesch
Infusionstherapie Und Klinische Ernahrung|June 1, 1986
[Possibilities for the use of formula diets for tumor patients]M Keymling, W Wörner
FEBS Letters|September 20, 1982
Kirromycin-resistant elongation factor Tu from wild-type of Lactobacillus brevisW Wörner, H Wolf
Beitrage Zu Infusionstherapie Und Klinische Ernahrung|January 1, 1986
[Possibilities for the use of formula diets in tumor patients]M Keymling, W Wörner
Environmental Toxicology and Pharmacology|July 26, 2011
2,3,7,8-Tetrachlorodibenzo-p-dioxin suppresses apoptosis and leads to hyperphosphorylation of p53 in rat hepatocytesW Wörner, D Schrenk
European Journal of Clinical Pharmacology|January 1, 1992
Drug-protein binding kinetics in patients with type I diabetesW Wörner, A Preissner, N Rietbrock
Deutsche Medizinische Wochenschrift (1946)|January 30, 1987
[Percutaneous endoscopy-controlled gastrostomy]M Keymling, P Schlee, W Wörner
Biochemical and Biophysical Research Communications|August 1, 1982
Kirromycin-resistant elongation factor Tu from pulvomycin-producing wild-type of Streptoverticillium mobaraenseC Glöckner, W Wörner, H Wolf
Pageof 4